KR20210106661A - Composition for improving skin whitening and anti-wrinkle comprising Hizikia fusiformis extract as effective component - Google Patents
Composition for improving skin whitening and anti-wrinkle comprising Hizikia fusiformis extract as effective component Download PDFInfo
- Publication number
- KR20210106661A KR20210106661A KR1020200021395A KR20200021395A KR20210106661A KR 20210106661 A KR20210106661 A KR 20210106661A KR 1020200021395 A KR1020200021395 A KR 1020200021395A KR 20200021395 A KR20200021395 A KR 20200021395A KR 20210106661 A KR20210106661 A KR 20210106661A
- Authority
- KR
- South Korea
- Prior art keywords
- skin
- extract
- skin whitening
- composition
- wrinkle improvement
- Prior art date
Links
- 239000000284 extract Substances 0.000 title claims abstract description 66
- 239000000203 mixture Substances 0.000 title claims abstract description 45
- 230000002087 whitening effect Effects 0.000 title claims abstract description 33
- 241000264279 Sargassum fusiforme Species 0.000 title claims abstract description 13
- 230000001153 anti-wrinkle effect Effects 0.000 title description 2
- 230000037303 wrinkles Effects 0.000 claims abstract description 33
- 230000006872 improvement Effects 0.000 claims abstract description 26
- 239000002537 cosmetic Substances 0.000 claims abstract description 25
- 235000013376 functional food Nutrition 0.000 claims abstract description 14
- 230000036541 health Effects 0.000 claims abstract description 14
- 239000004480 active ingredient Substances 0.000 claims abstract description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 52
- -1 body cleanser Substances 0.000 claims description 14
- 235000013305 food Nutrition 0.000 claims description 13
- 239000006210 lotion Substances 0.000 claims description 12
- 239000006071 cream Substances 0.000 claims description 11
- 238000009472 formulation Methods 0.000 claims description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 9
- 230000003796 beauty Effects 0.000 claims description 6
- 239000000843 powder Substances 0.000 claims description 5
- 239000002904 solvent Substances 0.000 claims description 4
- 239000000686 essence Substances 0.000 claims description 3
- 239000006260 foam Substances 0.000 claims description 2
- 239000008269 hand cream Substances 0.000 claims description 2
- 235000013336 milk Nutrition 0.000 claims description 2
- 239000008267 milk Substances 0.000 claims description 2
- 210000004080 milk Anatomy 0.000 claims description 2
- 239000000344 soap Substances 0.000 claims description 2
- 235000016709 nutrition Nutrition 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 27
- 230000002401 inhibitory effect Effects 0.000 abstract description 19
- 102000003425 Tyrosinase Human genes 0.000 abstract description 12
- 108060008724 Tyrosinase Proteins 0.000 abstract description 12
- 102000029816 Collagenase Human genes 0.000 abstract description 11
- 108060005980 Collagenase Proteins 0.000 abstract description 11
- 229960002424 collagenase Drugs 0.000 abstract description 11
- 102000016387 Pancreatic elastase Human genes 0.000 abstract description 10
- 108010067372 Pancreatic elastase Proteins 0.000 abstract description 10
- 108010016113 Matrix Metalloproteinase 1 Proteins 0.000 abstract description 9
- 102000000380 Matrix Metalloproteinase 1 Human genes 0.000 abstract description 9
- 238000004519 manufacturing process Methods 0.000 abstract description 8
- 230000008099 melanin synthesis Effects 0.000 abstract description 8
- 231100001083 no cytotoxicity Toxicity 0.000 abstract description 4
- 239000000463 material Substances 0.000 abstract description 2
- 210000003491 skin Anatomy 0.000 description 39
- 235000005206 Hibiscus Nutrition 0.000 description 25
- 235000007185 Hibiscus lunariifolius Nutrition 0.000 description 25
- 244000284380 Hibiscus rosa sinensis Species 0.000 description 23
- 238000002835 absorbance Methods 0.000 description 19
- 210000004027 cell Anatomy 0.000 description 17
- 239000004615 ingredient Substances 0.000 description 10
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 8
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 7
- 230000002292 Radical scavenging effect Effects 0.000 description 7
- MGJZITXUQXWAKY-UHFFFAOYSA-N diphenyl-(2,4,6-trinitrophenyl)iminoazanium Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1N=[N+](C=1C=CC=CC=1)C1=CC=CC=C1 MGJZITXUQXWAKY-UHFFFAOYSA-N 0.000 description 7
- 150000008442 polyphenolic compounds Chemical class 0.000 description 7
- 235000013824 polyphenols Nutrition 0.000 description 7
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- 230000003833 cell viability Effects 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 6
- 239000012153 distilled water Substances 0.000 description 6
- 239000000796 flavoring agent Substances 0.000 description 6
- 235000013355 food flavoring agent Nutrition 0.000 description 6
- 244000045195 Cicer arietinum Species 0.000 description 5
- 235000010523 Cicer arietinum Nutrition 0.000 description 5
- 102000004190 Enzymes Human genes 0.000 description 5
- 108090000790 Enzymes Proteins 0.000 description 5
- 235000013361 beverage Nutrition 0.000 description 5
- 235000014113 dietary fatty acids Nutrition 0.000 description 5
- 229940088598 enzyme Drugs 0.000 description 5
- 235000019441 ethanol Nutrition 0.000 description 5
- 239000000194 fatty acid Substances 0.000 description 5
- 229930195729 fatty acid Natural products 0.000 description 5
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 4
- 102000008186 Collagen Human genes 0.000 description 4
- 108010035532 Collagen Proteins 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- 229960005070 ascorbic acid Drugs 0.000 description 4
- 229920001436 collagen Polymers 0.000 description 4
- 230000003013 cytotoxicity Effects 0.000 description 4
- 231100000135 cytotoxicity Toxicity 0.000 description 4
- 239000012091 fetal bovine serum Substances 0.000 description 4
- 230000005764 inhibitory process Effects 0.000 description 4
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 description 4
- 229960004705 kojic acid Drugs 0.000 description 4
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- 201000001441 melanoma Diseases 0.000 description 4
- 239000013641 positive control Substances 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 4
- 239000011782 vitamin Substances 0.000 description 4
- 229940088594 vitamin Drugs 0.000 description 4
- 235000013343 vitamin Nutrition 0.000 description 4
- 229930003231 vitamin Natural products 0.000 description 4
- WMBWREPUVVBILR-WIYYLYMNSA-N (-)-Epigallocatechin-3-o-gallate Chemical compound O([C@@H]1CC2=C(O)C=C(C=C2O[C@@H]1C=1C=C(O)C(O)=C(O)C=1)O)C(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-WIYYLYMNSA-N 0.000 description 3
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 3
- WMBWREPUVVBILR-UHFFFAOYSA-N GCG Natural products C=1C(O)=C(O)C(O)=CC=1C1OC2=CC(O)=CC(O)=C2CC1OC(=O)C1=CC(O)=C(O)C(O)=C1 WMBWREPUVVBILR-UHFFFAOYSA-N 0.000 description 3
- 240000000599 Lentinula edodes Species 0.000 description 3
- 102400000740 Melanocyte-stimulating hormone alpha Human genes 0.000 description 3
- 101710200814 Melanotropin alpha Proteins 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 235000014633 carbohydrates Nutrition 0.000 description 3
- 235000014171 carbonated beverage Nutrition 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 230000001419 dependent effect Effects 0.000 description 3
- 230000002849 elastaseinhibitory effect Effects 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- 238000000338 in vitro Methods 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 230000003647 oxidation Effects 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- 235000018102 proteins Nutrition 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- WHNFPRLDDSXQCL-UAZQEYIDSA-N α-msh Chemical compound C([C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(N)=O)NC(=O)[C@H](CO)NC(C)=O)C1=CC=C(O)C=C1 WHNFPRLDDSXQCL-UAZQEYIDSA-N 0.000 description 3
- WCGUUGGRBIKTOS-GPOJBZKASA-N (3beta)-3-hydroxyurs-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C WCGUUGGRBIKTOS-GPOJBZKASA-N 0.000 description 2
- 102100030310 5,6-dihydroxyindole-2-carboxylic acid oxidase Human genes 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 2
- 241001474374 Blennius Species 0.000 description 2
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical class OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 2
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 241000218033 Hibiscus Species 0.000 description 2
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 239000002211 L-ascorbic acid Substances 0.000 description 2
- 235000000069 L-ascorbic acid Nutrition 0.000 description 2
- 102100031413 L-dopachrome tautomerase Human genes 0.000 description 2
- 235000001715 Lentinula edodes Nutrition 0.000 description 2
- 102000002274 Matrix Metalloproteinases Human genes 0.000 description 2
- 108010000684 Matrix Metalloproteinases Proteins 0.000 description 2
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 2
- 229920002230 Pectic acid Polymers 0.000 description 2
- 229930182555 Penicillin Natural products 0.000 description 2
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 235000010419 agar Nutrition 0.000 description 2
- 239000000783 alginic acid Substances 0.000 description 2
- 235000010443 alginic acid Nutrition 0.000 description 2
- 229920000615 alginic acid Polymers 0.000 description 2
- 229960001126 alginic acid Drugs 0.000 description 2
- 150000004781 alginic acids Chemical class 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000003078 antioxidant effect Effects 0.000 description 2
- 235000010323 ascorbic acid Nutrition 0.000 description 2
- 239000011668 ascorbic acid Substances 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 239000000440 bentonite Substances 0.000 description 2
- 229910000278 bentonite Inorganic materials 0.000 description 2
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 2
- SESFRYSPDFLNCH-UHFFFAOYSA-N benzyl benzoate Chemical compound C=1C=CC=CC=1C(=O)OCC1=CC=CC=C1 SESFRYSPDFLNCH-UHFFFAOYSA-N 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 238000011088 calibration curve Methods 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 210000002808 connective tissue Anatomy 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 108010051081 dopachrome isomerase Proteins 0.000 description 2
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 2
- 229940093915 gynecological organic acid Drugs 0.000 description 2
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 2
- 230000036564 melanin content Effects 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 235000005985 organic acids Nutrition 0.000 description 2
- LCLHHZYHLXDRQG-ZNKJPWOQSA-N pectic acid Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)O[C@H](C(O)=O)[C@@H]1OC1[C@H](O)[C@@H](O)[C@@H](OC2[C@@H]([C@@H](O)[C@@H](O)[C@H](O2)C(O)=O)O)[C@@H](C(O)=O)O1 LCLHHZYHLXDRQG-ZNKJPWOQSA-N 0.000 description 2
- 229940049954 penicillin Drugs 0.000 description 2
- 239000000419 plant extract Substances 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 239000010318 polygalacturonic acid Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- GHMLBKRAJCXXBS-UHFFFAOYSA-N resorcinol Chemical compound OC1=CC=CC(O)=C1 GHMLBKRAJCXXBS-UHFFFAOYSA-N 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- 229960005322 streptomycin Drugs 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 239000000454 talc Substances 0.000 description 2
- 229910052623 talc Inorganic materials 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- 108010014402 tyrosinase-related protein-1 Proteins 0.000 description 2
- 229940096998 ursolic acid Drugs 0.000 description 2
- PLSAJKYPRJGMHO-UHFFFAOYSA-N ursolic acid Natural products CC1CCC2(CCC3(C)C(C=CC4C5(C)CCC(O)C(C)(C)C5CCC34C)C2C1C)C(=O)O PLSAJKYPRJGMHO-UHFFFAOYSA-N 0.000 description 2
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- 150000005208 1,4-dihydroxybenzenes Chemical class 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical class CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 description 1
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- OWIRCRREDNEXTA-UHFFFAOYSA-N 3-nitro-1h-indazole Chemical compound C1=CC=C2C([N+](=O)[O-])=NNC2=C1 OWIRCRREDNEXTA-UHFFFAOYSA-N 0.000 description 1
- 241001280436 Allium schoenoprasum Species 0.000 description 1
- 235000001270 Allium sibiricum Nutrition 0.000 description 1
- 241001116389 Aloe Species 0.000 description 1
- 244000144730 Amygdalus persica Species 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241001481710 Cerambycidae Species 0.000 description 1
- 241000675108 Citrus tangerina Species 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- 208000001333 Colorectal Neoplasms Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- 244000000626 Daucus carota Species 0.000 description 1
- 235000002767 Daucus carota Nutrition 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 238000008157 ELISA kit Methods 0.000 description 1
- 239000004278 EU approved seasoning Substances 0.000 description 1
- AFSDNFLWKVMVRB-UHFFFAOYSA-N Ellagic acid Chemical compound OC1=C(O)C(OC2=O)=C3C4=C2C=C(O)C(O)=C4OC(=O)C3=C1 AFSDNFLWKVMVRB-UHFFFAOYSA-N 0.000 description 1
- ATJXMQHAMYVHRX-CPCISQLKSA-N Ellagic acid Natural products OC1=C(O)[C@H]2OC(=O)c3cc(O)c(O)c4OC(=O)C(=C1)[C@H]2c34 ATJXMQHAMYVHRX-CPCISQLKSA-N 0.000 description 1
- 229920002079 Ellagic acid Polymers 0.000 description 1
- 206010014970 Ephelides Diseases 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- 240000003537 Ficus benghalensis Species 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 241000206672 Gelidium Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 101001013150 Homo sapiens Interstitial collagenase Proteins 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 241000220225 Malus Species 0.000 description 1
- 235000011430 Malus pumila Nutrition 0.000 description 1
- 235000015103 Malus silvestris Nutrition 0.000 description 1
- 239000000637 Melanocyte-Stimulating Hormone Substances 0.000 description 1
- 108010007013 Melanocyte-Stimulating Hormones Proteins 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 235000006040 Prunus persica var persica Nutrition 0.000 description 1
- 235000014443 Pyrus communis Nutrition 0.000 description 1
- 240000001987 Pyrus communis Species 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 244000228451 Stevia rebaudiana Species 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- ULUAUXLGCMPNKK-UHFFFAOYSA-N Sulfobutanedioic acid Chemical compound OC(=O)CC(C(O)=O)S(O)(=O)=O ULUAUXLGCMPNKK-UHFFFAOYSA-N 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 101710147108 Tyrosinase inhibitor Proteins 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 235000013334 alcoholic beverage Nutrition 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 235000011399 aloe vera Nutrition 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 229960000271 arbutin Drugs 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 238000003149 assay kit Methods 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 229960002903 benzyl benzoate Drugs 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 239000001273 butane Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 235000001465 calcium Nutrition 0.000 description 1
- 239000000378 calcium silicate Substances 0.000 description 1
- 229910052918 calcium silicate Inorganic materials 0.000 description 1
- OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 150000005827 chlorofluoro hydrocarbons Chemical class 0.000 description 1
- 235000019219 chocolate Nutrition 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 229960002852 ellagic acid Drugs 0.000 description 1
- 235000004132 ellagic acid Nutrition 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 229940030275 epigallocatechin gallate Drugs 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 229930003949 flavanone Natural products 0.000 description 1
- 150000002208 flavanones Chemical class 0.000 description 1
- 235000011981 flavanones Nutrition 0.000 description 1
- HVQAJTFOCKOKIN-UHFFFAOYSA-N flavonol Chemical class O1C2=CC=CC=C2C(=O)C(O)=C1C1=CC=CC=C1 HVQAJTFOCKOKIN-UHFFFAOYSA-N 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 239000005417 food ingredient Substances 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 239000000417 fungicide Substances 0.000 description 1
- 235000004515 gallic acid Nutrition 0.000 description 1
- 229940074391 gallic acid Drugs 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 239000003752 hydrotrope Substances 0.000 description 1
- 235000015243 ice cream Nutrition 0.000 description 1
- MTNDZQHUAFNZQY-UHFFFAOYSA-N imidazoline Chemical class C1CN=CN1 MTNDZQHUAFNZQY-UHFFFAOYSA-N 0.000 description 1
- 239000000411 inducer Substances 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- SUMDYPCJJOFFON-UHFFFAOYSA-N isethionic acid Chemical compound OCCS(O)(=O)=O SUMDYPCJJOFFON-UHFFFAOYSA-N 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 229940069445 licorice extract Drugs 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 210000002752 melanocyte Anatomy 0.000 description 1
- 230000003061 melanogenesis Effects 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- FAARLWTXUUQFSN-UHFFFAOYSA-N methylellagic acid Natural products O1C(=O)C2=CC(O)=C(O)C3=C2C2=C1C(OC)=C(O)C=C2C(=O)O3 FAARLWTXUUQFSN-UHFFFAOYSA-N 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- CQDGTJPVBWZJAZ-UHFFFAOYSA-N monoethyl carbonate Chemical compound CCOC(O)=O CQDGTJPVBWZJAZ-UHFFFAOYSA-N 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 1
- OFBQJSOFQDEBGM-UHFFFAOYSA-N n-pentane Natural products CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 1
- 235000012149 noodles Nutrition 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 235000013550 pizza Nutrition 0.000 description 1
- 230000003169 placental effect Effects 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 150000004804 polysaccharides Chemical class 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- 239000003380 propellant Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000003642 reactive oxygen metabolite Substances 0.000 description 1
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- 229940071089 sarcosinate Drugs 0.000 description 1
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical compound C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 description 1
- 235000013580 sausages Nutrition 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 210000002374 sebum Anatomy 0.000 description 1
- 230000037307 sensitive skin Effects 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 230000004215 skin function Effects 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 235000011888 snacks Nutrition 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 230000000475 sunscreen effect Effects 0.000 description 1
- 239000000516 sunscreening agent Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 229940104261 taurate Drugs 0.000 description 1
- 235000013616 tea Nutrition 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 235000015193 tomato juice Nutrition 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9706—Algae
- A61K8/9711—Phaeophycota or Phaeophyta [brown algae], e.g. Fucus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
- A23V2200/318—Foods, ingredients or supplements having a functional effect on health having an effect on skin health and hair or coat
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2250/00—Food ingredients
- A23V2250/20—Natural extracts
- A23V2250/202—Algae extracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/92—Oral administration
Abstract
Description
본 발명은 톳 추출물을 유효성분으로 함유하는 피부 미백 및 주름 개선용 조성물에 관한 것이다.The present invention relates to a composition for skin whitening and anti-wrinkle improvement comprising a hibiscus extract as an active ingredient.
피부는 외부자극으로부터 우리 몸을 보호해주는 인체 최전방의 방어 장기이며, 미적인 관점에서도 그 관심이 점점 높아지고 있다. 이에 따라 다양한 기능성 화장품에 대한 연구가 활발한데, 그 중에서도 주름 완화 및 미백 기능에 대한 다양한 기능성 화장품들이 출시되고 있는 실정이다.The skin is the first defense organ of the human body that protects our body from external stimuli, and the interest in it is increasing from an aesthetic point of view. Accordingly, research on various functional cosmetics is active, and among them, various functional cosmetics for wrinkle relief and whitening functions are being released.
주름의 생성 원인으로는 여러 가지가 보고되고 있는데, 우선 피부가 과다한 자외선에 노출되면 피부 구성성분인 콜라겐(collagen) 분해가 촉진되어 피부가 탄력을 잃고 주름이 생성될 수 있다. 또한, 피부가 과도한 온도 변화 및 습도 저하나 바람 등에 의해 지나치게 건조해지면 외부에 대한 방어벽으로서의 피부 기능이 저하되어 주름이 생기기도 한다. 그리고, 피부가 활성 산소종이나 자유 라디칼에 노출되면 산화 작용에 의해 과산화 지질이 생성되고 그로 인해 콜라겐 등의 피부 구성 단백질이 변형되어 주름이 생성될 수 있다. 이러한 외부적 요인과 내부적 요인에 의한 주름 발생을 억제하고자 다양한 화장품 조성물이 연구되고 있는 실정이다.Various causes of wrinkles have been reported. First, when the skin is exposed to excessive ultraviolet rays, the decomposition of collagen, which is a component of the skin, is promoted, so that the skin loses elasticity and wrinkles can be generated. In addition, when the skin becomes too dry due to excessive temperature change, humidity drop, wind, etc., the skin function as a barrier to the outside decreases, and wrinkles may occur. In addition, when the skin is exposed to reactive oxygen species or free radicals, lipid peroxide is generated by oxidation, and thus, skin constituent proteins such as collagen are deformed and wrinkles can be generated. Various cosmetic compositions are being studied to suppress the occurrence of wrinkles due to these external and internal factors.
한편, 피부에 자외선이 조사되면 피부 중 멜라노사이트(melanocyte)가 활성화되어 티로시나아제(tyrosinase)와 TRP1(tyrosinase related protein 1) 및 TRP2(tyrosinase related protein 2)의 작용에 의해 멜라닌 생성이 촉진된다. 생성된 멜라닌은 피부에 침착되어 검버섯 또는 주근깨로 발전하는데, 이것을 방지하기 위하여 다양한 조성물이 함유된 미백 화장품이 사용되고 있다. 또한, 자외선은 피지, 세포막 등의 산화를 촉진하여 각종 피부장애를 일으키는 것으로 밝혀지고 있으며, 특히 최근 오존층 파괴에 따른 자외선의 증가로 보다 효과적인 피부 산화 방지책이 요구되는 실정이다.On the other hand, when the skin is irradiated with ultraviolet rays, melanocytes in the skin are activated and melanin production is promoted by the action of tyrosinase, tyrosinase related protein 1 (TRP1) and tyrosinase related protein 2 (TRP2). The produced melanin is deposited on the skin and develops into age spots or freckles. In order to prevent this, whitening cosmetics containing various compositions are used. In addition, ultraviolet rays have been found to cause various skin disorders by promoting the oxidation of sebum and cell membranes, and in particular, more effective skin oxidation prevention measures are required due to the recent increase in ultraviolet rays due to the destruction of the ozone layer.
종래 알려진 미백 효과를 나타내는 성분은 아스코르브산, 인산 에스테르염, 하이드로퀴논 유도체, 태반 추출물, 코지산, 엘라그산 등이 있으며, 이들 성분을 배합한 화장품 조성물이 일반적이다. 최근에는 식물에 함유된 폴리페놀 등에 높은 미백 효과가 있는 것으로 보고되어 있으며, 이를 사용하는 화장품 조성물이 제안되고 있다. 또한, 플라바논류(flavanones) 및 하이드록시플라본류(hydroxyflavones)의 미백 효과에 대해서도 이미 개시되어 있다. 그러나, 이들 미백 성분은 그 효과가 다소 미비하고 보존시 문제점이 있으며, 미백 효과 이외에 주름 완화 효과 및 노화 방지 효과를 충분히 발휘하지 못하는 실정이다. 특히 화학성분이 함유된 기능성 화장품의 경우 피부 자극을 유발하여 민감성 피부에 적합하지 않은 문제점이 있는바, 피부에 자극이 적고 친환경적인 천연 식물 유래의 기능성 화장품에 대한 관심이 집중되고 있다.Ascorbic acid, phosphoric acid ester salts, hydroquinone derivatives, placental extracts, kojic acid, ellagic acid, and the like are known conventionally known ingredients for a whitening effect, and cosmetic compositions containing these ingredients are common. Recently, it has been reported that polyphenols contained in plants have a high whitening effect, and cosmetic compositions using the same have been proposed. In addition, the whitening effect of flavanones and hydroxyflavones has already been disclosed. However, these whitening ingredients are somewhat ineffective and have problems during storage, and in addition to the whitening effect, they do not sufficiently exhibit the wrinkle-relieving effect and anti-aging effect. In particular, functional cosmetics containing chemical ingredients cause skin irritation and are not suitable for sensitive skin, so there is little irritation to the skin and interest in eco-friendly, natural plant-derived functional cosmetics.
톳(Hizikia fusiformis)은 우리나라의 중남 이남부에 분포하고, 특히 제주도와 서남해안에서 많이 생산되며 갈조류 모자반과에 속하며 형태는 원주상의 줄기로 체장 20~100cm까지 성장하는 다년생 해조류이다. 톳은 독특한 맛과 함께 칼슘, 비타민 A 및 식이섬유소 함량이 풍부하여 당뇨병, 고혈압, 대장암, 변비 등에 효과가 좋으며 요오드 성분 함량이 많아 갑상선암 및 각기병 예방에 효과가 있다고 알려져 있다. Hizikia fusiformis (Hizikia fusiformis) is a perennial seaweed that is distributed in the south-central and south-central parts of Korea, and is especially produced in Jeju Island and the southwest coast. As it has a unique taste and is rich in calcium, vitamin A and dietary fiber, it is effective for diabetes, high blood pressure, colorectal cancer, and constipation.
한편, 한국공개특허 제2013-0023326호에는 '모자반, 우뭇가사리, 톳으로 구성된 해조류 추출물을 함유하는 항알러지, 진정 및 보습 효과가 우수한 화장료 조성물'에 대해 개시하고 있으며, 한국등록특허 제1589002호에는 '톱니모자반 추출물 또는 이의 분획물을 유효성분으로 포함하는 주름개선용 화장료 조성물'에 대해 개시하고 있다. 하지만, 본 발명의 '톳 추출물을 유효성분으로 함유하는 피부 미백 및 주름 개선용 조성물'에 대해서는 아직까지 개시된 바가 없다.On the other hand, Korea Patent Application Publication No. 2013-0023326 discloses 'a cosmetic composition with excellent anti-allergic, soothing and moisturizing effects containing a seaweed extract composed of hat banyan, agar agar, and chives'. It discloses a 'cosmetic composition for wrinkle improvement comprising a Serrated Capricorn extract or a fraction thereof as an active ingredient. However, the 'composition for skin whitening and wrinkle improvement containing the extract of the present invention' as an active ingredient has not yet been disclosed.
본 발명은 상기와 같은 요구에 의해 도출된 것으로서, 본 발명자들은 톳의 열수 추출물을 제조하고 그 기능을 시험해 본 결과, 톳 열수 추출물이 티로시나아제 활성 및 멜라닌 합성을 저해하고, 엘라스타아제, 콜라게나아제 활성 및 MMP-1 생성을 억제하는 것을 확인함으로써, 본 발명을 완성하였다.The present invention was derived from the above needs, and as a result of the present inventors preparing a hot water extract of Hibiscus and testing its function, the hot water extract of Hibiscus inhibits tyrosinase activity and melanin synthesis, and elastase, cola By confirming that genase activity and MMP-1 production were inhibited, the present invention was completed.
상기 과제를 해결하기 위하여, 본 발명은 톳(Hizikia fusiformis) 추출물을 유효성분으로 함유하는 피부 미백 또는 주름 개선용 화장료 조성물을 제공한다.In order to solve the above problems, the present invention provides a cosmetic composition for skin whitening or wrinkle improvement containing an extract of Hizikia fusiformis as an active ingredient.
또한, 본 발명은 톳(Hizikia fusiformis) 추출물을 유효성분으로 함유하는 피부 미백 또는 주름 개선용 건강기능식품 조성물을 제공한다.In addition, the present invention provides a health functional food composition for skin whitening or wrinkle improvement containing an extract of Hizikia fusiformis as an active ingredient.
본 발명의 톳 추출물은 세포독성이 없어 피부에 안전하며, 티로시나아제 활성 및 멜라닌 생성을 저해하고, 엘라스타아제, 콜라게나아제 활성 및 MMP-1 생성을 억제하는 피부 미백 및 주름 생성 개선 효과가 우수하므로, 피부 미백 및 주름 개선을 위한 기능성 화장품 또는 건강기능식품의 소재로 유용하게 사용될 수 있을 것이다.The extract of the present invention has no cytotoxicity, so it is safe for the skin, inhibits tyrosinase activity and melanin production, and has skin whitening and wrinkle improvement effects by inhibiting elastase, collagenase activity and MMP-1 production. Because it is excellent, it may be usefully used as a material for functional cosmetics or health functional food for skin whitening and wrinkle improvement.
도 1은 본 발명의 톳 열수 추출물을 B16F10 세포에 처리하였을 때, 세포 생존율을 측정한 결과이다. C: 무처리 대조군.
도 2는 본 발명의 톳 열수 추출물의 멜라닌 생성 저해효과를 확인한 결과이다. α-MSH: 멜라닌 생성 유도 물질.
도 3은 본 발명의 톳 열수 추출물을 CCD-986SK 세포에 처리하였을 때, 세포 생존율을 측정한 결과이다. C: 무처리 대조군.
도 4는 본 발명의 톳 열수 추출물의 MMP-1(Matrix metalloproteinase-1) 생성 저해 효과를 확인한 결과이다. C: 무처리 대조군.1 is a result of measuring cell viability when B16F10 cells are treated with a hot water extract of the present invention. C: untreated control.
2 is a result confirming the melanin production inhibitory effect of the hot water extract of the present invention. α-MSH: melanogenesis inducer.
3 is a result of measuring cell viability when CCD-986SK cells are treated with a hot water extract of the present invention. C: untreated control.
4 is a result confirming the inhibitory effect of MMP-1 (Matrix metalloproteinase-1) production of the hot water extract of the present invention. C: untreated control.
본 발명의 목적을 달성하기 위하여, 본 발명은 톳(Hizikia fusiformis) 추출물을 유효성분으로 함유하는 피부 미백 또는 주름 개선용 화장료 조성물을 제공한다.In order to achieve the object of the present invention, the present invention provides a cosmetic composition for skin whitening or wrinkle improvement containing an extract of Hizikia fusiformis as an active ingredient.
본 발명의 피부 미백 또는 주름 개선용 화장료 조성물에서, 상기 추출물은 물, C1~C4의 저급 알코올 또는 이들의 혼합물을 용매로 추출하여 제조할 수 있으며, 바람직하게는 물로 추출하여 제조할 수 있으나, 이에 제한되지 않는다.In the cosmetic composition for skin whitening or wrinkle improvement of the present invention, the extract may be prepared by extracting water, a C 1 to C 4 lower alcohol or a mixture thereof with a solvent, and preferably by extracting with water. , but not limited thereto.
또한, 상기 상기 화장료 조성물은 스킨, 스킨 소프트너, 스킨토너, 아스트린젠트, 로션, 밀크로션, 모이스쳐로션, 영양로션, 마사지크림, 영양크림, 아이 크림, 모이스쳐 크림, 핸드크림, 에센스, 영양에센스, 팩, 클렌징폼, 클렌징 워터, 클렌징 로션, 클렌징 크림, 바디로션, 바디클렌져, 비누 및 파우더로 이루어진 군으로부터 선택되는 어느 하나의 제형으로 제조될 수 있으나, 이에 제한되지 않는다. 이들 각 제형의 조성물은 그 제형의 제제화에 필요하고 적절한 각종의 기제와 첨가물을 함유할 수 있으며, 이들 성분의 종류와 양은 당업자에 의해 용이하게 선정될 수 있다.In addition, the cosmetic composition is a skin, skin softener, skin toner, astringent, lotion, milk lotion, moisture lotion, nourishing lotion, massage cream, nourishing cream, eye cream, moisture cream, hand cream, essence, nourishing essence, pack , cleansing foam, cleansing water, cleansing lotion, cleansing cream, body lotion, body cleanser, soap and powder may be prepared in any one formulation selected from the group consisting of, but is not limited thereto. The composition of each of these formulations may contain various bases and additives necessary and appropriate for the formulation of the formulation, and the types and amounts of these components can be easily selected by those skilled in the art.
본 발명의 화장료 조성물은 상기 유효성분 이외에 추가로 동일 또는 유사한 기능을 나타내는 피부 미백 또는 주름 개선용 성분을 1종 이상 함유할 수 있다. 피부 미백 피부 미백 또는 주름 개선용 성분으로는 코지산 및 이의 유도체, 알부틴, 아스코르브산 및 이의 유도체, 히드로퀴논 및 이의 유도체, 레조르시놀, 사이클로알카논, 메틸렌디옥시페닐 알칸올, 2,7-디니트로인다졸 또는 덩굴귤 추출물, 쌀 추출물, 감초 추출물과 같은 식물 추출물 등이 있으나, 이에 제한되는 것은 아니다.The cosmetic composition of the present invention may contain one or more ingredients for skin whitening or wrinkle improvement that exhibit the same or similar function in addition to the above active ingredients. Skin whitening Ingredients for skin whitening or wrinkle improvement include kojic acid and its derivatives, arbutin, ascorbic acid and its derivatives, hydroquinone and its derivatives, resorcinol, cycloalkanone, methylenedioxyphenyl alkanol, 2,7-di plant extracts such as nitroindazole or tendril extract, rice extract, and licorice extract, but are not limited thereto.
본 발명의 제형이 페이스트, 크림 또는 겔인 경우에는 담체 성분으로서 동물섬유, 식물섬유, 왁스, 파라핀, 전분, 트라칸트, 셀룰로오스 유도체, 폴리에틸렌 글리콜, 실리콘, 벤토나이트, 실리카, 탈크 또는 산화아연 등이 이용될 수 있다.When the formulation of the present invention is a paste, cream or gel, animal fiber, vegetable fiber, wax, paraffin, starch, tracanth, cellulose derivative, polyethylene glycol, silicone, bentonite, silica, talc or zinc oxide may be used as a carrier component. can
본 발명의 제형이 파우더 또는 스프레이인 경우에는 담체 성분으로서 락토스, 탈크, 실리카, 알루미늄 히드록시드, 칼슘 실리케이트 또는 폴리아미드 파우더가 이용될 수 있고, 특히 스프레이인 경우에는 추가로 클로로플루오로히드로카본, 프로판/부탄 또는 디메틸 에테르와 같은 추진체를 포함할 수 있다.When the formulation of the present invention is a powder or a spray, lactose, talc, silica, aluminum hydroxide, calcium silicate or polyamide powder may be used as a carrier component. In particular, in the case of a spray, additional chlorofluorohydrocarbon, propellants such as propane/butane or dimethyl ether.
본 발명의 제형이 용액 또는 유탁액의 경우에는 담체 성분으로서 용매, 용매화제 또는 유탁화제가 이용되고, 예컨대 물, 에탄올, 이소프로판올, 에틸 카보네이트, 에틸 아세테이트, 벤질 알코올, 벤질 벤조에이트, 프로필렌글리콜, 1,3-부틸글리콜 오일, 글리세롤 지방족 에스테르, 폴리에틸렌 글리콜 또는 소르비탄의 지방산 에스테르가 있다.When the formulation of the present invention is a solution or emulsion, a solvent, solvating agent or emulsifying agent is used as a carrier component, for example, water, ethanol, isopropanol, ethyl carbonate, ethyl acetate, benzyl alcohol, benzyl benzoate, propylene glycol, 1 ,3-butylglycol oil, glycerol fatty esters, fatty acid esters of polyethylene glycol or sorbitan.
본 발명의 제형이 현탁액인 경우에는 담체 성분으로서 물, 에탄올 또는 프로필렌 글리콜과 같은 액상 희석제, 에톡실화 이소스테아릴 알코올, 폴리옥시에틸렌 소르비톨 에스테르 및 폴리옥시에틸렌 소르비탄 에스테르와 같은 현탁제, 미소결정성 셀룰로오스, 알루미늄 메타히드록시드, 벤토나이트, 아가 또는 트라칸트 등이 이용될 수 있다.When the formulation of the present invention is a suspension, as a carrier component, water, a liquid diluent such as ethanol or propylene glycol, a suspending agent such as ethoxylated isostearyl alcohol, polyoxyethylene sorbitol esters and polyoxyethylene sorbitan esters, microcrystalline Cellulose, aluminum metahydroxide, bentonite, agar or tracanth may be used.
본 발명의 제형이 계면-활성제 함유 클렌징인 경우에는 담체 성분으로서 지방족 알코올 설페이트, 지방족 알코올 에테르설페이트, 설포숙신산 모노에스테르, 이세티오네이트, 이미다졸리늄 유도체, 메틸타우레이트, 사르코시네이트, 지방산 아미드 에테르 설페이트, 알킬아미도베타인, 지방족 알코올, 지방산 글리세리드, 지방산 디에탄올아미드, 식물성 유, 리놀린 유도체 또는 에톡실화 글리세롤 지방산 에스테르 등이 이용될 수 있다.When the formulation of the present invention is a surfactant-containing cleansing agent, aliphatic alcohol sulfate, aliphatic alcohol ether sulfate, sulfosuccinic acid monoester, isethionate, imidazolinium derivative, methyl taurate, sarcosinate, fatty acid amide as carrier components Ether sulfate, alkylamidobetaine, aliphatic alcohol, fatty acid glyceride, fatty acid diethanolamide, vegetable oil, linolin derivative or ethoxylated glycerol fatty acid ester and the like can be used.
본 발명의 화장료 조성물은 살진균제, 굴수성 유발물질, 보습제, 방향제, 방향제 담체, 단백질, 용해화제, 당 유도체, 일광차단제, 비타민, 식물 추출물 등을 포함하는 부형제를 추가로 함유할 수 있다.The cosmetic composition of the present invention may further contain excipients including fungicides, hydrotropes, moisturizers, fragrances, fragrance carriers, proteins, solubilizers, sugar derivatives, sunscreens, vitamins, plant extracts, and the like.
본 발명은 또한, 톳(Hizikia fusiformis) 추출물을 유효성분으로 함유하는 피부 미백 또는 주름 개선용 건강기능식품 조성물을 제공한다.The present invention also provides a health functional food composition for skin whitening or wrinkle improvement containing an extract of Hizikia fusiformis as an active ingredient.
본 발명의 피부 미백 또는 주름 개선용 건강기능식품 조성물에서, 상기 톳 추출물은 전술한 바와 같다.In the health functional food composition for skin whitening or wrinkle improvement of the present invention, the extract of hibiscus is the same as described above.
본 발명의 피부 미백 또는 주름 개선용 건강기능식품 조성물은 분말, 과립, 환, 정제, 캡슐, 캔디, 시럽 및 음료로 이루어진 군으로부터 선택된 하나의 제형으로 제조할 수 있으나 이에 제한되지 않는다. 바람직하게는, 상기 피부 미백 또는 주름 개선용 건강기능성 식품은 이너뷰티(inner beauty) 식품 형태로 섭취함으로써 더욱 우수한 효과를 갖는 장점을 가진다. 상기 이너뷰티(inner beauty) 식품은 '먹는 화장품 또는 뷰티 식품'으로 일컬어지는 식품으로, 피부에 좋은 여러 가지 성분을 몸속으로 흡수시켜 피부 체질을 건강하게 바꾸는 식품을 지칭하며, 피부 타입에 맞는 화장품을 고르듯 피부 컨디션과 라이프스타일을 고려해 개개인에게 맞는 이너뷰티 식품을 선택하여 섭취할 수 있다. 보다 바람직하게는 상기 톳 추출물을 포함하는 화장품과 상기 추출물을 포함하는 이너뷰티 식품을 혼용할 경우, 화장품만 사용하는 것에 비해 티로시나아제 활성 및 멜라닌 합성을 저해하고, 엘라스타아제, 콜라게나아제 활성 및 MMP-1 생성을 억제하는 효과가 월등히 높아져 더욱 효과적으로 피부 미백 및 주름 개선 효과를 볼 수 있는 장점을 가진다.The health functional food composition for skin whitening or wrinkle improvement of the present invention may be prepared in one formulation selected from the group consisting of powders, granules, pills, tablets, capsules, candy, syrups and beverages, but is not limited thereto. Preferably, the health functional food for skin whitening or wrinkle improvement has the advantage of having a more excellent effect by ingesting it in the form of an inner beauty food. The inner beauty food is a food called 'eating cosmetics or beauty food', which refers to food that absorbs various ingredients good for the skin into the body and changes the skin constitution to make it healthy. As you choose, you can choose and consume inner beauty foods that are suitable for you by considering your skin condition and lifestyle. More preferably, when mixing the cosmetic containing the extract and the inner beauty food containing the extract, compared to using only cosmetics, tyrosinase activity and melanin synthesis are inhibited, and elastase and collagenase activity And the effect of inhibiting the production of MMP-1 is significantly increased, so it has the advantage of being able to see the skin whitening and wrinkle improvement effect more effectively.
또한, 상기 식품의 종류에는 특별한 제한은 없다. 상기 건강기능식품 조성물을 첨가할 수 있는 식품의 예로는 육류, 소시지, 빵, 초콜릿, 캔디류, 스낵류, 과자류, 피자, 라면, 기타 면류, 껌류, 아이스크림류를 포함한 낙농제품, 각종 스프, 음료수, 차 드링크제, 알콜 음료 및 비타민 복합제 등이 있으며, 통상적인 의미에서의 건강식품을 모두 포함한다. 상기 음료는 탄산음료, 기능성이온음료, 쥬스(예를 들어, 사과, 배,포도, 알로에, 감귤, 복숭아, 당근, 토마토쥬스 등), 식혜 등을 포함한다.In addition, there is no particular limitation on the type of the food. Examples of foods to which the health functional food composition can be added include meat, sausage, bread, chocolate, candy, snacks, confectionery, pizza, ramen, other noodles, gum, dairy products including ice cream, various soups, beverages, tea There are drinks, alcoholic beverages, vitamin complexes, and the like, and includes all health foods in the ordinary sense. The beverage includes carbonated beverages, functional ionic beverages, juices (eg, apple, pear, grape, aloe, tangerine, peach, carrot, tomato juice, etc.), sikhye, and the like.
본 발명의 톳 추출물을 식품첨가물로 사용하는 경우, 상기 톳 추출물을 그대로 첨가하거나 다른 식품 또는 식품성분과 함께 사용될 수 있고, 통상적인 방법에 따라 적절하게 사용될 수 있다. 유효성분은 그의 사용 목적(예방 또는 개선)에 따라 적절하게 사용될 수 있다. 일반적으로, 식품 또는 음료의 제조시에 본 발명의 톳 추출물은 원료에 대하여 15 중량부 이하, 바람직하게는 10 중량부 이하의 양의로 첨가된다. 그러나 건강 조절을 목적으로 하는 장기간의 섭취의 경우에는 안전성 면에서 아무런 문제가 없는 범위의 양으로 사용될 수 있다.In the case of using the hibiscus extract of the present invention as a food additive, the hibiscus extract may be added as it is or used together with other foods or food ingredients, and may be suitably used according to a conventional method. The active ingredient may be used appropriately depending on the purpose of its use (prevention or improvement). In general, in the production of food or beverage, the extract of the present invention is added in an amount of 15 parts by weight or less, preferably 10 parts by weight or less, based on the raw material. However, in the case of long-term intake for the purpose of health control, it can be used in an amount within a range that does not cause any problems in terms of safety.
본 발명의 기능성 식품은 식품 제조 시에 통상적으로 첨가되는 성분을 포함하며, 예를 들어, 단백질, 탄수화물, 지방, 영양소 및 조미제를 포함한다. 예컨대, 드링크제로 제조되는 경우에는 유효성분 이외에 천연 탄수화물 또는 향미제를 추가 성분으로서 포함시킬 수 있다. 상기 천연 탄수화물은 모노사카라이드(예컨대, 글루코오스, 프럭토오스 등), 디사카라이드(예컨대, 말토스, 수크로오스 등), 올리고당, 폴리사카라이드(예컨대, 덱스트린, 시클로덱스트린 등) 또는 당알코올(예컨대, 자일리톨, 소르비톨, 에리쓰리톨 등)인 것이 바람직하다. 상기 향미제는 천연 향미제(예컨대, 타우마틴, 스테비아 추출물 등)와 합성 향미제(예컨대, 사카린, 아스파르탐 등)를 이용할 수 있다. 상기 건강기능식품 조성물 외에 여러가지 영양제, 비타민, 전해질, 풍미제, 착색제, 펙트산 및 그의 염, 알긴산 및 그의 염, 유기산, 보호성 콜로이드 증점제, pH 조절제, 안정화제, 방부제, 글리세린, 알콜, 탄산음료에 사용되는 탄산화제 등을 더 함유할 수 있다.The functional food of the present invention includes ingredients commonly added during food production, for example, proteins, carbohydrates, fats, nutrients and seasonings. For example, when manufactured as a drink, natural carbohydrates or flavoring agents may be included as additional ingredients in addition to the active ingredient. The natural carbohydrates include monosaccharides (eg, glucose, fructose, etc.), disaccharides (eg, maltose, sucrose, etc.), oligosaccharides, polysaccharides (eg, dextrin, cyclodextrin, etc.) or sugar alcohols (eg, , xylitol, sorbitol, erythritol, etc.). As the flavoring agent, natural flavoring agents (eg, taumatine, stevia extract, etc.) and synthetic flavoring agents (eg, saccharin, aspartame, etc.) may be used. In addition to the above health functional food composition, various nutrients, vitamins, electrolytes, flavoring agents, coloring agents, pectic acid and its salts, alginic acid and its salts, organic acids, protective colloidal thickeners, pH adjusters, stabilizers, preservatives, glycerin, alcohol, carbonated beverages It may further contain a carbonation agent, etc. used for
상기 건강기능식품 조성물 이외에 여러 가지 영양제, 비타민, 저해질, 풍미제, 착색제, 펙트산 및 그의 염, 알긴산 및 그의 염, 유기산, 보호성 콜로이드 증점제, pH 조절제, 안정화제, 방부제, 글리세린, 알콜, 탄산음료에 사용되는 탄산화제 등을 더 함유할 수 있다. 이러한 상기 첨가되는 성분의 비율은 크게 중요하진 않지만 본 발명의 건강기능식품 조성물 100 중량부에 대하여, 0.01 내지 0.1 중량부의 범위에서 선택되는 것이 일반적이다.In addition to the above health functional food composition, various nutrients, vitamins, inhibitors, flavoring agents, coloring agents, pectic acid and its salts, alginic acid and its salts, organic acids, protective colloidal thickeners, pH adjusters, stabilizers, preservatives, glycerin, alcohols, It may further contain a carbonation agent, etc. used in carbonated beverages. The ratio of these added ingredients is not very important, but is generally selected in the range of 0.01 to 0.1 parts by weight based on 100 parts by weight of the health functional food composition of the present invention.
이하, 본 발명의 실시예에 의해 상세히 설명한다. 단, 하기 실시예는 본 발명을 예시하는 것일 뿐, 본 발명의 내용이 하기 실시예에 한정되는 것은 아니다.Hereinafter, an embodiment of the present invention will be described in detail. However, the following examples only illustrate the present invention, and the content of the present invention is not limited to the following examples.
제조예 1. 톳 열수 추출물의 제조Preparation Example 1. Preparation of hot water extract of hibiscus
톳(Hizikia fusiformis)은 흐르는 물에 1회 세척하고, 증류수에 1회 세척한 후, 2kg의 톳 대비 4배의 증류수를 첨가하고 100℃에서 3~4분 동안 추출하여 톳 열수 추출물(이하 '시료'라 칭함)을 획득하였다. 이후에, Brix(%)를 측정하여 당도(0.4 브릭스)를 확인하고 동결건조하여 하기 실시예에 사용하였다. Hizikia fusiformis ) was washed once in running water, washed once in distilled water, and distilled water 4 times that of 2 kg of hibiscus was added and extracted at 100 ° C for 3-4 minutes. ) was obtained. Thereafter, the Brix (%) was measured to confirm the sugar content (0.4 Brix), and lyophilized to be used in the following Examples.
실시예 1. 총 폴리페놀 함량 및 DPPH 라디칼 소거활성 측정Example 1. Measurement of total polyphenol content and DPPH radical scavenging activity
총 폴리페놀 함량은 폴린-데니스(Folin-Denis) 방법을 이용하여 측정하였다. 톳 열수 추출물과 페놀용액(Folin-ciocalteu's phenol reagent)을 1:1로 혼합하고 3분간 반응시킨 후 10%(w/v) Na2CO3를 서서히 첨가하였다. 이를 암실에서 1시간 동안 반응시킨 후 이를 725nm에서 흡광도를 측정하여 측정하였다. 이때 표준 검량 곡선은 갈산(gallic acid)을 일정 농도(0~500μg/㎖)로 하여 상기와 동일한 방법으로 측정하여 획득하였으며, 시료의 흡광도를 표준 검량 곡선에 대입하여 총 폴리페놀 함량을 mg/g로 나타내었다. 그 결과, 톳 열수 추출물에서 17.1mg/g의 총 폴리페놀 함량이 측정되었다(표 1).Total polyphenol content was determined using the Folin-Denis method. The hot water extract and phenol solution (Folin-ciocalteu's phenol reagent) were mixed 1:1 and reacted for 3 minutes, and then 10% (w/v) Na 2 CO 3 was slowly added. After reacting this for 1 hour in the dark, it was measured by measuring the absorbance at 725 nm. At this time, the standard calibration curve was obtained by measuring gallic acid at a certain concentration (0 to 500 μg/ml) in the same manner as above, and substituting the absorbance of the sample into the standard calibration curve to determine the total polyphenol content in mg/g indicated as As a result, a total polyphenol content of 17.1 mg/g was measured in the hot water extract of hibiscus (Table 1).
또한, DPPH 라디칼 소거 활성(radical scavenging activity)은 톳 열수 추출물과 0.2mM DPPH(1,1-diphenyl-2-picrylhydrazyl)를 1:1로 반응시켜 암실에서 30분간 반응시킨 후 528nm에서 흡광도를 측정하였다. 이때 활성 비교를 위하여 기존에 항산화제로 많이 사용되고 있는 L-아스코르브산(L-Ascorbic acid, 250μM)을 양성 대조군으로 사용하여 시료와 동일한 방법으로 흡광도를 측정하였다. DPPH를 이용한 항산화 활성은 시료 첨가구와 무첨가구의 흡광도차를 백분율(%)로 표시하였다. DPPH 라디칼 소거능 활성을 구하는 식은 하기와 같다. 그 결과, 톳 열수 추출물의 DPPH 라디칼 소거 활성이 72.7%인 것을 확인하였다(표 2).In addition, DPPH radical scavenging activity was measured by reacting hot water extract with 0.2 mM DPPH (1,1-diphenyl-2-picrylhydrazyl) 1:1 in a dark room for 30 minutes and then absorbance at 528 nm. . At this time, the absorbance was measured in the same manner as the sample using L-Ascorbic acid (250 μM), which has been widely used as an antioxidant, as a positive control for activity comparison. Antioxidant activity using DPPH was expressed as a percentage (%) of the absorbance difference between the sample-added group and the non-additive group. The formula for calculating the DPPH radical scavenging activity is as follows. As a result, it was confirmed that the DPPH radical scavenging activity of the hot water extract of hibiscus was 72.7% (Table 2).
DPPH 라디칼 소거 활성(%)=[1-(시료 흡광도528nm/대조구 흡광도528nm)]×100DPPH radical scavenging activity (%) = [1- (sample absorbance 528 nm / control absorbance 528 nm )] × 100
실시예 2. 피부 미백 및 세포독성 Example 2. Skin whitening and cytotoxicity
1) One) in vitroin vitro 티로시나아제 저해 활성 Tyrosinase inhibitory activity
티로시나아제 저해 활성은 Tyrosinase Inhibitor Assay Kit(ab204715, abcam)를 사용하여 농도별 톳 열수 추출물과 반응시킨 후, 510nm에서 흡광도를 측정하였으며, 양성 대조군으로 코직산(Kojic acid, 0.75mM)을 사용하였다. 티로시나아제 저해 활성을 구하는 식은 하기와 같다. 그 결과, 톳 열수 추출물은 농도 의존적으로 티로시나아제 저해 활성이 증가하는 경향을 나타내었다(표 3). Tyrosinase inhibitory activity was measured using a Tyrosinase Inhibitor Assay Kit (ab204715, abcam) after reacting with hot water extract of each concentration, and then absorbance was measured at 510 nm, and Kojic acid (0.75 mM) was used as a positive control. The formula for obtaining the tyrosinase inhibitory activity is as follows. As a result, the hot water extract of hibiscus showed a tendency to increase the tyrosinase inhibitory activity in a concentration-dependent manner (Table 3).
티로시나아제 저해 활성(%)=[1-(시료 흡광도510nm/무첨가 흡광도510nm)]×100Tyrosinase inhibitory activity (%) = [1- (sample absorbance 510 nm / absorbance without addition 510 nm )] × 100
2) 세포독성 2) Cytotoxicity
톳 열수 추출물이 B16F10 멜라노마 세포에 미치는 영향을 측정하기 위해, B16F10 멜라노마 세포를 이용하여 MTT(3-(4,5-dimethylthaiazol-2-yl)-2,5-diphenyltetrazolium bromide) 분석을 수행하였다. B16F10 세포는 10% FBS(fetal bovine serum)와 1% 페니실린 및 1% 스트렙토마이신이 함유된 DMEM(Dulbeco's Modified Eagle's Media)을 사용하였으며, 5% CO2 및 37℃ 조건으로 배양하였다. 배지는 2일 간격으로 교환하였고 80% 컨플루언트 상태(confluent status)에서 트립신-EDTA를 처리하여 계대 배양하였다. 96 웰 플레이트에 B16F10 세포(1×103 세포/웰)를 24시간 동안 배양한 후, 50, 100 및 200㎍/㎖의 톳 열수 추출물을 각각 처리하여 72시간 후 2㎎/㎖의 MTT 용액을 넣고 4시간 동안 반응시켰다. 이후에 MTT 용액 제거 후 DMSO(dimethyl sulfoxide)를 첨가하고 암실에서 30분간 반응시킨 후 540nm에서 흡광도를 측정하였다. 세포 생존율(cell viability)은 톳 열수 추출물을 처리하지 않은 대조군 값과 비교하여 산출하였다. 그 결과, 톳 열수 추출물의 모든 처리군에서 세포독성이 없는 것을 확인하였다(도 1). In order to measure the effect of hot water extract of hibiscus on B16F10 melanoma cells, MTT (3-(4,5-dimethylthaiazol-2-yl)-2,5-diphenyltetrazolium bromide) analysis was performed using B16F10 melanoma cells. . B16F10 cells were used with DMEM (Dulbeco's Modified Eagle's Media) containing 10% fetal bovine serum (FBS), 1% penicillin and 1% streptomycin, and cultured at 5% CO 2 and 37°C conditions. The medium was exchanged every 2 days and subcultured by treatment with trypsin-EDTA at 80% confluent status. After culturing B16F10 cells (1×10 3 cells/well) in a 96-well plate for 24 hours, 50, 100, and 200 μg/ml of hot water extract of hibiscus were treated, respectively, and 2 mg/ml of MTT solution was added after 72 hours. and reacted for 4 hours. Then, after removing the MTT solution, DMSO (dimethyl sulfoxide) was added and the reaction was carried out in the dark for 30 minutes, and absorbance was measured at 540 nm. Cell viability (cell viability) was calculated by comparing the value of the control group that was not treated with the hot water extract of hibiscus. As a result, it was confirmed that there was no cytotoxicity in all the treatment groups of the hot water extract of hibiscus (Fig. 1).
3) 멜라닌 생성 억제3) Inhibition of melanin production
B16F10 멜라노마 세포를 이용하여 톳 열수 추출물이 멜라닌 합성에 미치는 영향을 확인하였다. 구체적으로, B16F10 세포를 6 웰 플레이트에 5×104 세포/웰이 되도록 접종하여 24시간 동안 배양한 후, 각 웰에 멜라닌 생성 유도물질인 α-MSH(melanocyte-stimulating hormone) 및 톳 열수 추출물(50, 75 및 100㎍/㎖)을 동시에 72시간 동안 처리하였다. 72시간 후 배지를 제거하고 인산완충액(phosphatate buffer saline, PBS)으로 2회 세척한 후 부착된 세포를 원심분리하여 얻은 펠렛(pellet)에 10% DMSO가 함유된 1N NaOH 용액 200㎕를 첨가하고 80℃에서 1시간 방치하여 용해시킨 후 475nm에서 흡광도를 측정하였다. 그 결과, 도 2에 개시한 바와 같이 α-MSH 처리에 의해 증가된 멜라닌 함량이 톳 열수 추출물에 의해 감소되는 것을 확인할 수 있었고, 톳 열수 추출물의 처리농도가 증가함에 따라 멜라닌 함량이 보다 더 감소하는 경향을 나타내었다. Using B16F10 melanoma cells, the effect of hot water extract of hibiscus on melanin synthesis was confirmed. Specifically, B16F10 cells were inoculated into a 6-well plate at 5×10 4 cells/well and cultured for 24 hours, and then melanocyte-stimulating hormone (α-MSH) and hot water extract ( 50, 75 and 100 μg/ml) were treated simultaneously for 72 hours. After 72 hours, the medium was removed, washed twice with phosphate buffer (phosphatate buffer saline, PBS), and 200 μl of 1N NaOH solution containing 10% DMSO was added to the pellet obtained by centrifuging the adhered cells and 80 After dissolution by standing at ℃ for 1 hour, absorbance was measured at 475 nm. As a result, as shown in FIG. 2 , it was confirmed that the melanin content increased by α-MSH treatment was reduced by the hot water extract of hibiscus, and the melanin content was further decreased as the treatment concentration of the hot water extract of hibiscus increased. showed a trend.
실시예 3. 피부 주름 생성 및 세포독성Example 3. Skin Wrinkle Generation and Cytotoxicity
1) One) in vitroin vitro 엘라스타아제 활성 저해 Inhibition of elastase activity
톳 열수 추출물이 피부 주름의 주된 원인인 엘라스타아제 활성을 저해하는지 그 효과를 확인하였다. 구체적으로, 96 웰 플레이트에 100mM Tris-HCl 버퍼(pH 8.0), 톳 열수 추출물, 2.9mM AAAPVN(N-succinyl-(L-Ala)3-p-nitroanilide)를 첨가하고 10분간 방치한 후, 돼지 췌장 엘라스타아제(porcine pancreas elastase, 0.2 unit) 용액을 가하고 25℃에서 10분간 반응시킨 다음 410nm에서 흡광도를 측정하였다. 대조군으로는 톳 열수 추출물 대신 증류수를 가해 효소의 활성을 측정하였으며, 활성 비교를 위해 양성 대조군으로 우르솔릭산(Ursolic acid, 0.5 mM)을 사용하였다. 엘라스타아제의 저해 활성을 구하는 식은 하기와 같다. 그 결과, 표 4에 개시한 바와 같이 톳 열수 추출물은 농도 의존적으로 엘라스타아제 활성을 저해하는 것을 확인하였다. It was confirmed whether the hot water extract of hibiscus inhibited the activity of elastase, which is the main cause of skin wrinkles. Specifically, 100mM Tris-HCl buffer (pH 8.0), hibiscus hot water extract, and 2.9mM AAAPVN (N-succinyl-(L-Ala)3-p-nitroanilide) were added to a 96-well plate and left for 10 minutes. A solution of pancreatic elastase (porcine pancreas elastase, 0.2 unit) was added and reacted at 25° C. for 10 minutes, and then absorbance was measured at 410 nm. As a control, distilled water was added instead of the hot water extract of hibiscus to measure the enzyme activity, and ursolic acid (0.5 mM) was used as a positive control for activity comparison. The formula for determining the inhibitory activity of elastase is as follows. As a result, as shown in Table 4, it was confirmed that the hot water extract of hibiscus inhibited the elastase activity in a concentration-dependent manner.
엘라스타아제(Elastase) 저해 활성(%)=[1-(B-C)/(A-D)]×100Elastase inhibitory activity (%) = [1- (B-C) / (A-D)] × 100
A: 시료 대신 증류수를 넣고 효소를 첨가하여 반응한 후의 흡광도A: Absorbance after reaction by adding distilled water instead of sample and adding enzyme
B: 효소를 첨가하여 반응한 후 시료의 흡광도B: Absorbance of sample after reaction by adding enzyme
C: 효소 대신 증류수를 첨가하여 반응한 후 시료의 흡광도C: Absorbance of sample after reaction by adding distilled water instead of enzyme
D: 시료와 효소 대신 각각 증류수를 첨가해 반응한 후의 흡광도D: Absorbance after reaction by adding distilled water instead of sample and enzyme
2) 2) in vitroin vitro 콜라게나아제 활성 저해 Inhibition of collagenase activity
피부세포 결합 조직을 구성하는 콜라겐의 분해는 결합 조직의 탄력 저하와 주름 생성 등에 직접적인 영향을 미친다. 따라서 톳 열수 추출물의 콜라게나아제(collagenase) 저해 활성을 측정하여 피부 주름 개선 효과를 확인하고자 하였다. 콜라게나아제 저해 활성은 0.3mg/mL의 4-페닐아조벤질옥시카보닐-Pro-Leu-Gly-Pro-Agr(4-phenylazovenzyloxycarbonyl-Pro-Leu-Gly-Pro-Arg) 및 톳 열수 추출물(100, 200 및 500㎍/㎖)에 0.2mg/mL의 콜라게나아제를 첨가하여 25℃에서 20분간 방치한 다음 6% 시트르산(citric acid)을 넣어 반응을 정지시켰다. 그런 다음, 100% 에틸 아세테이트(ethyl acetate)를 첨가한 후 상등액을 취하고 320nm에서 흡광도를 측정하여 콜라게나아제 저해 활성을 산출하였으며, 활성 비교를 위해 양성 대조군으로 EGCG(epigallocatechin gallate, 2mM)를 사용하였다. 그 결과, 톳 열수 추출물의 콜라게나아제 저해 활성은 농도 의존적으로 증가되는 것을 확인하였다(표 5). The decomposition of collagen, which constitutes the skin cell connective tissue, directly affects the decrease in elasticity of the connective tissue and the generation of wrinkles. Therefore, by measuring the collagenase inhibitory activity of the hot water extract of hibiscus, it was attempted to confirm the skin wrinkle improvement effect. Collagenase inhibitory activity was determined by 0.3 mg/mL of 4-phenylazobenzyloxycarbonyl-Pro-Leu-Gly-Pro-Agr (4-phenylazovenzyloxycarbonyl-Pro-Leu-Gly-Pro-Arg) and hot water extract (100 , 200 and 500 μg/ml) were added with 0.2 mg/mL of collagenase, left at 25° C. for 20 minutes, and then 6% citric acid was added to stop the reaction. Then, after adding 100% ethyl acetate, the supernatant was taken and absorbance was measured at 320 nm to calculate collagenase inhibitory activity, and EGCG (epigallocatechin gallate, 2 mM) was used as a positive control for activity comparison. . As a result, it was confirmed that the collagenase inhibitory activity of the hot water extract of H. shiitake was increased in a concentration-dependent manner (Table 5).
3) 세포독성 3) Cytotoxicity
CCD-986SK 멜라노마 세포를 이용하여 MTT 분석을 수행하였다. CCD-986SK 세포는 10% FBS(fetal bovine serum)와 1% 페니실린 및 1% 스트렙토마이신이 함유된 DMEM(Dulbeco's Modified Eagle's Media)을 사용하였으며, 5% CO2 및 37℃ 조건으로 배양하였다. 배지는 2일 간격으로 교환하였고 80% 컨플루언트 상태(confluent status)에서 트립신-EDTA를 처리하여 계대 배양하였다. 96 웰 플레이트에 CCD-986SK 세포(1×103 세포/웰)를 24시간 동안 배양한 후 50, 100 및 200㎍/㎖의 톳 열수 추출물을 각각 처리하여 24시간 후 2㎎/㎖의 MTT 용액을 넣고 4시간 동안 반응시켰다. 이후에 MTT 용액 제거 후 DMSO를 첨가하고 암실에서 30분간 반응시킨 후 540nm에서 흡광도를 측정하였다. 세포 생존율(cell viability)은 톳 열수 추출물을 처리하지 않은 대조군 값과 비교하여 산출하였다. 그 결과, 50, 100 및 200㎍/㎖의 톳 열수 추출물을 처리하였을 때 세포독성이 없음을 확인하였다(도 3). MTT analysis was performed using CCD-986SK melanoma cells. For CCD-986SK cells, DMEM (Dulbeco's Modified Eagle's Media) containing 10% fetal bovine serum (FBS), 1% penicillin and 1% streptomycin was used, and cultured at 5% CO 2 and 37°C conditions. The medium was exchanged every 2 days and subcultured by treatment with trypsin-EDTA at 80% confluent status. After culturing CCD-986SK cells (1×10 3 cells/well) in a 96-well plate for 24 hours, 50, 100, and 200 μg/ml hot water extract of shiitake shiitake extract were treated, respectively, and 2 mg/ml MTT solution after 24 hours. was added and reacted for 4 hours. After the removal of the MTT solution, DMSO was added, and the absorbance was measured at 540 nm after reacting in the dark for 30 minutes. Cell viability (cell viability) was calculated by comparing the value of the control group that was not treated with the hot water extract of hibiscus. As a result, it was confirmed that there was no cytotoxicity when 50, 100 and 200 μg/ml of hot water extract of hibiscus was treated (FIG. 3).
4) MMP-1 생성 억제4) Inhibition of MMP-1 production
콜라겐 감소에 중요한 영향을 미치는 기질 금속단백질 분해 효소(MMPs; matrix metalloproteinases)의 발현량의 변화를 분석함으로써, 톳 열수 추출물의 주름개선 효과가 있는지 여부를 확인하였다. CCD-986SK 세포를 48 웰 플레이트에 웰당 5×104 세포가 되도록 접종한 후 24시간 동안 배양하고, 톳 열수 추출물을 농도(100, 150 및 200㎍/㎖)별로 처리하여 48시간 동안 배양한 후, Human MMP-1 ELISA Kit(Sigma-Aldrich)를 이용하여 제조업자의 프로토콜에 따라 사용하여 MMP-1 함량을 측정하였다. 그 결과, 무처리 대조군(C)에 비해 톳 열수 추출물 처리군에서 MMP-1 함량이 약 36~52% 감소된 것을 확인하였다(도 4).By analyzing the change in the expression level of matrix metalloproteinases (MMPs), which has an important effect on the reduction of collagen, it was confirmed whether or not the wrinkle-improving effect of hot water shiitake extract. CCD-986SK cells were inoculated in a 48-well plate to 5×10 4 cells per well and cultured for 24 hours. , MMP-1 content was measured using the Human MMP-1 ELISA Kit (Sigma-Aldrich) according to the manufacturer's protocol. As a result, it was confirmed that the MMP-1 content was reduced by about 36-52% in the hot water extract treated group compared to the untreated control group (C) (FIG. 4).
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020200021395A KR20210106661A (en) | 2020-02-21 | 2020-02-21 | Composition for improving skin whitening and anti-wrinkle comprising Hizikia fusiformis extract as effective component |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020200021395A KR20210106661A (en) | 2020-02-21 | 2020-02-21 | Composition for improving skin whitening and anti-wrinkle comprising Hizikia fusiformis extract as effective component |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20210106661A true KR20210106661A (en) | 2021-08-31 |
Family
ID=77489406
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020200021395A KR20210106661A (en) | 2020-02-21 | 2020-02-21 | Composition for improving skin whitening and anti-wrinkle comprising Hizikia fusiformis extract as effective component |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR20210106661A (en) |
-
2020
- 2020-02-21 KR KR1020200021395A patent/KR20210106661A/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101936294B1 (en) | Composition comprising for skin-whitening and anti-wrinkling extract of Rumex acetosella L. or extract of Hydrangea serrata | |
KR102539619B1 (en) | Composition for improving skin conditions comprising Praeruptorin A | |
KR102283040B1 (en) | Cosmetic or pharmaceutical composition for skin whitening, elasticity, anti-wrinkle, or skin moisturizing comprising atractylenolide I | |
KR102128168B1 (en) | Composition comprising the extract of Lentinula edodes and Acer pictum subsp. mono leaf for antioxidant effect | |
KR20210106661A (en) | Composition for improving skin whitening and anti-wrinkle comprising Hizikia fusiformis extract as effective component | |
KR20170078259A (en) | Composition for improving skin conditions comprising Isosteviol | |
KR20210129476A (en) | Cosmetic composition containing Albiggia kalkora extract for skin whitening and improving wrinkles | |
KR20160020242A (en) | Cosmetic or pharmaceutical composition for melanism, elasticity, anti-wrinkle, or skin moisturizing comprising parthenolide | |
KR20160020223A (en) | Cosmetic or pharmaceutical composition for skin whitening, elasticity, anti-wrinkle, or skin moisturizing comprising Shanzhiside methylester or a pharmaceutically acceptable salt thereof | |
KR102503190B1 (en) | Composition for improving skin conditions comprising Ajugol | |
KR102515649B1 (en) | Cosmetic composition for skin whitening and anti-wrinkle comprising extract of steamed Polygonatum sibiricum as effective componenet | |
KR102356144B1 (en) | Cosmetic composition and health functional food for skin whitening and anti-wrinkle | |
KR102305237B1 (en) | Compositions for Improving Skin Wrinkles and Skin Whitening Using an Extract of Persicaria filiforme | |
KR102662257B1 (en) | Composition for skin improvement containing rebaudioside C | |
KR20170076429A (en) | Composition for improving skin conditions comprising Polygalasaponin F | |
KR20160020241A (en) | Cosmetic or pharmaceutical composition for skin whitening, elasticity, anti-wrinkle, or skin moisturizing comprising prim-O-glucosylcimifugin or a pharmaceutically acceptable salt thereof | |
KR20160019815A (en) | Cosmetic or pharmaceutical composition for skin whitening, elasticity, anti-wrinkle, or skin moisturizing comprising Esculentoside A or a pharmaceutically acceptable salt thereof | |
KR20160020250A (en) | Cosmetic or pharmaceutical composition for skin whitening, elasticity, anti-wrinkle, or skin moisturizing comprising Wogonoside or a pharmaceutically acceptable salt thereof | |
KR102523361B1 (en) | Composition for improving skin conditions comprising Dihydrotanshinone I | |
KR102503188B1 (en) | Composition for improving skin conditions comprising Gaultherin | |
KR102503108B1 (en) | Composition for improving skin conditions comprising Timosaponin A-Ⅲ | |
KR102512773B1 (en) | Composition for improving skin conditions comprising bavachinin A | |
KR20230033388A (en) | Compositions for Improving Skin Wrinkles and Skin Whitening Using an Extract of Veratrum versicolor | |
KR20160019765A (en) | Cosmetic or pharmaceutical composition for melanism, elasticity, anti-wrinkle, or skin moisturizing comprising dihydroartemisinin | |
KR102245313B1 (en) | Cosmetic or pharmaceutical composition for skin whitening, elasticity, anti-wrinkle, or skin moisturizing comprising Sclareol or a pharmaceutically acceptable salt thereof |